Home
Eric Venker, President & Immunovant CEO: Roivant Sciences ROIV Sell · Filed 25/10/17
Trade details
- Type
- Insider sale
- Amount
- $7,020,583.19
- Shares · price
- 414,683 sh · $16.93 a share
- Held after
- 1,504,959 sh
- Trade date
- 25/10/15
- Filed
- 25/10/17
- Days to filing
- 2 days
Sold 21.6% of holdings
- Share of holding sold
- 21.6%
Roivant Sciences trades, last 26 weeks
What else happened in Roivant Sciences around then
Filed or reported within 30 days of the trade day · 25/09/15~25/11/14Eric Venker's recent trades
- Eric Venker
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 planRoivant Sciences
ROIV
$7.3M
200,000 sh
$7.3M
Filed 09/30
Traded 09/30
- Eric Venker
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 planRoivant Sciences
ROIV
$7.1M
200,000 sh
$7.1M
Filed 08/28
Traded 08/28
- Eric Venker
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 planRoivant Sciences
ROIV
$7M
200,000 sh
$7M
Filed 07/27
Traded 07/27
- Eric Venker
Sell10b5-1 planRoivant Sciences
Sell10b5-1 planRoivant Sciences
ROIV
$5.1M
153,766 sh
$5.1M
Filed 06/26
Traded 06/24
- Eric Venker
Sell10b5-1 planRoivant Sciences
Sell10b5-1 planRoivant Sciences
ROIV
$1.5M
46,234 sh
$1.5M
Filed 06/26
Traded 06/24